Puu, Margareta
AstraZeneca (Sweden)
2 papers on CoChat
Most cited papers
- Verified
Atrial Fibrillation and Risk of Clinical Events in Chronic Heart Failure With and Without Left Ventricular Systolic Dysfunction
Olsson, L. G., Swedberg, K., Ducharme, A., Granger, C. B., Michelson, E. L., McMurray, J. J. V., Puu, M., Yusuf, S., & Pfeffer, M. A. (2006) · Journal of the American College of Cardiology
Atrial Fibrillation Management and OutcomesHeart Failure Treatment and Management
Cited by 574
- Verified
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program
Ducharme, A., Swedberg, K., Pfeffer, M. A., Cohen-Solal, A., Granger, C. B., Maggioni, A. P., Michelson, E. L., McMurray, J. J. V., Olsson, L., Rouleau, J. L., et al. (2006) · American Heart Journal
Atrial Fibrillation Management and OutcomesHeart Failure Treatment and Management
Cited by 352
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free